Argenx Se ADR (ARGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARGX | REGN | ALNY | ||
| Company | Argenx Se ADR | Regeneron Pharmaceuticals | Alnylam Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 706.13 | 750.00 | 311.22 | ||
| High | 709.29 | 763.30 | 319.55 | ||
| Low | 701.17 | 747.01 | 311.22 | ||
| Latest | 703.30 | 756.91 | 318.91 | ||
| Change | +2.85 | +11.14 | +5.50 | ||
| % Change | +0.41% | +1.49% | +1.75% | ||
| Volume | 246,400 | 396,200 | 1,247,400 | ||
| 20-Day Average Volume | 367,420 | 613,210 | 1,092,720 | ||
| Previous Close | 700.45 | 745.77 | 313.41 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 771.37 | 774.55 | 326.14 | ||
| 20-Day Raw Stochastic | 5.77% | 20.54% | 25.64% | ||
| 20-Day Relative Strength | 31.77 | 47.80 | 40.54 | ||
| Weighted Alpha | +7.37 | +23.45 | -2.75 | ||
| Today's Opinion | 56% Sell | 64% Buy | 100% Sell | ||
| Previous Opinion | 40% Sell | 64% Buy | 88% Sell | ||
| Last Month's Opinion | 32% Buy | 96% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.01% since 03/09/26 | -3.16% since 03/09/26 | -1.45% since 03/09/26 | ||
| Low | 694.14 on 03/13/26 | 741.90 on 03/13/26 | 309.61 on 03/12/26 | ||
| High | 748.30 on 03/10/26 | 788.69 on 03/10/26 | 326.18 on 03/10/26 | ||
| 1-Month | |||||
| %Chg | -14.44% since 02/13/26 | -5.76% since 02/13/26 | +1.43% since 02/13/26 | ||
| Low | 694.14 on 03/13/26 | 741.90 on 03/13/26 | 309.61 on 03/12/26 | ||
| High | 852.83 on 02/17/26 | 815.00 on 02/17/26 | 345.89 on 02/20/26 | ||
| 3-Month | |||||
| %Chg | -17.40% since 12/16/25 | +1.41% since 12/16/25 | -18.47% since 12/16/25 | ||
| Low | 694.14 on 03/13/26 | 718.38 on 01/20/26 | 298.00 on 02/12/26 | ||
| High | 881.89 on 01/27/26 | 821.11 on 01/09/26 | 427.05 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | -6.52% since 09/16/25 | +31.62% since 09/16/25 | -30.86% since 09/16/25 | ||
| Low | 694.14 on 03/13/26 | 541.00 on 10/13/25 | 298.00 on 02/12/26 | ||
| High | 934.62 on 12/03/25 | 821.11 on 01/09/26 | 495.55 on 10/20/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 43,522,304 | 80,020,528 | 42,294,800 | ||
| Shares Outstanding, K | 61,883 | 105,720 | 132,623 | ||
| Annual Sales | 4,248,050,000 | 14,342,900,000 | 3,713,940,000 | ||
| Annual Net Income | 1,292,040,000 | 4,504,900,000 | 313,750,000 | ||
| Last Quarter Sales | 1,322,160,000 | 3,884,300,000 | 1,097,030,000 | ||
| Last Quarter Net Income | 532,950,000 | 844,600,000 | 186,420,000 | ||
| 60-Month Beta | 0.38 | 0.40 | 0.36 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 8.02 on 02/26/26 | 11.44 on 01/30/26 | 1.25 on 02/12/26 | ||
| Latest Earnings Date | 05/14/26 | 05/05/26 | 05/07/26 | ||
| Most Recent Dividend | N/A | 0.940 on 02/20/26 | N/A | ||
| Next Ex-Dividends Date | N/A | 02/20/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 35.88 | 20.67 | 184.36 | ||